Profile data is unavailable for this security.
About the company
Supriya Lifescience Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs). The Company is primarily engaged in the manufacturing of bulk drugs and pharmaceutical chemicals. The Company exports its products in the antihistamine, anesthetics and anti-asthma therapy categories to approximately 86 countries. The Company's product portfolio consists of approximately 38 API products that offer remedies in therapeutic segments, such as antihistamines, analgesics, vitamins, anesthetics and anti-asthmatics, among others. Its products include Chlorphenamine Maleate, Pheniramine Maleate, Brompheniramine Maleate, Dexchlorpheniramine Maleate, Mepyramine / Pyrilamine Maleate, Dexbrompheniramine Maleate, Cetirizine DiHCL, Diphenhydramine HCL, Bisoprolol Fumarate, Nicorandil, Mecobalamin, Hydroxocobalamin Sulfate, Hydroxocobalamin Acetate, and Hydroxocobalamin Hydrochloride, among others. The Company has manufacturing facilities located in Maharashtra.
- Revenue in INR (TTM)7.35bn
- Net income in INR1.85bn
- Incorporated2008
- Employees515.00
- LocationSupriya Lifescience LtdSonawala Road Goregoan207/208, Udyog BhavanMUMBAI 400 063IndiaIND
- Phone+91 2 240332727
- Fax+91 2 226860011
- Websitehttps://supriyalifescience.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd | 27.97bn | 1.19bn | 31.63bn | 1.11k | 26.64 | -- | 7.06 | 1.13 | 7.57 | 7.57 | 178.50 | -- | -- | -- | -- | 25,287,880.00 | -- | -0.7247 | -- | -0.9005 | 84.96 | 74.27 | 4.25 | -2.77 | -- | 1.31 | -- | -- | 3.66 | 5.82 | 102.11 | -54.07 | -11.91 | -- |
| RPG Life Sciences Ltd | 6.74bn | 2.03bn | 32.66bn | 1.33k | 16.12 | -- | 14.60 | 4.85 | 122.51 | 122.51 | 407.37 | -- | -- | -- | -- | 5,061,758.00 | -- | 21.05 | -- | 27.78 | 64.34 | 63.28 | 30.07 | 16.68 | -- | 174.47 | -- | 24.92 | 12.26 | 11.71 | 109.03 | 44.58 | 27.39 | 37.97 |
| Orchid Pharma Ltd | 8.21bn | 522.57m | 33.70bn | 737.00 | 64.46 | 2.65 | 38.74 | 4.10 | 10.31 | 10.31 | 162.05 | 251.16 | 0.4893 | 1.58 | 3.94 | 11,143,480.00 | 3.10 | 1.40 | 3.63 | 1.72 | 39.83 | 35.89 | 6.33 | 2.75 | 1.90 | 2.18 | 0.181 | -- | 12.48 | 13.76 | 8.13 | -- | 104.06 | -- |
| Aarti Drugs Ltd | 25.22bn | 2.03bn | 33.93bn | 1.28k | 16.84 | -- | 12.74 | 1.35 | 22.07 | 22.07 | 274.99 | -- | -- | -- | -- | 19,639,960.00 | -- | 9.09 | -- | 14.39 | 36.35 | 22.09 | 8.03 | 8.08 | -- | 7.00 | -- | 6.07 | -5.60 | 5.74 | -1.90 | 3.53 | 29.85 | 14.87 |
| Gujarat Themis Biosyn Ltd | 1.59bn | 477.88m | 34.02bn | 221.00 | 71.20 | -- | 58.78 | 21.36 | 4.39 | 4.39 | 14.62 | -- | -- | -- | -- | 7,209,322.00 | -- | 30.70 | -- | 34.37 | 62.78 | 68.03 | 29.99 | 35.51 | -- | 55.73 | -- | -- | -11.20 | 12.12 | -17.56 | 15.55 | 104.61 | 24.95 |
| Senores Pharmaceuticals Ltd | 5.89bn | 1.02bn | 36.09bn | 194.00 | 34.97 | -- | 27.75 | 6.13 | 22.41 | 22.41 | 130.31 | -- | -- | -- | -- | 30,336,080.00 | -- | -- | -- | -- | 58.73 | -- | 17.48 | -- | -- | 5.94 | -- | -- | 85.64 | -- | 86.17 | -- | -- | -- |
| Innova Captab Ltd | 14.97bn | 1.32bn | 38.85bn | 1.95k | 29.34 | -- | 22.07 | 2.60 | 23.13 | 23.13 | 261.52 | -- | -- | -- | -- | 7,676,703.00 | -- | 10.02 | -- | 15.00 | 36.26 | 27.20 | 8.85 | 8.72 | -- | 12.45 | -- | -- | 15.02 | 27.21 | 35.95 | 35.69 | 109.94 | -- |
| Sun Pharma Advanced Research Co Ltd | 531.36m | -2.68bn | 42.87bn | 316.00 | -- | -- | -- | 80.68 | -8.26 | -8.26 | 1.64 | -- | -- | -- | -- | 1,681,519.00 | -- | -60.53 | -- | -129.98 | -4.34 | -3.83 | -504.20 | -168.34 | -- | -8.82 | -- | -- | -5.00 | -1.35 | 11.55 | -- | -28.16 | -- |
| Zota Health Care Ltd | 4.73bn | -726.58m | 48.76bn | 519.00 | -- | -- | -- | 10.31 | -23.98 | -23.98 | 157.24 | -- | -- | -- | -- | 9,108,992.00 | -- | -7.79 | -- | -10.57 | 57.22 | 42.02 | -15.34 | -8.01 | -- | -3.71 | -- | -- | 62.32 | 25.23 | -293.08 | -- | 49.40 | 0.00 |
| Supriya Lifescience Ltd | 7.35bn | 1.85bn | 54.80bn | 515.00 | 29.54 | -- | 25.94 | 7.45 | 23.05 | 23.05 | 91.47 | -- | -- | -- | -- | 14,280,700.00 | -- | 18.45 | -- | 21.63 | 72.33 | 59.62 | 25.19 | 25.45 | -- | 129.43 | -- | 3.59 | 22.11 | 17.45 | 57.80 | 20.69 | 45.94 | -- |
| F D C Ltd | 20.78bn | 2.17bn | 61.27bn | 6.86k | 28.27 | -- | 22.11 | 2.95 | 13.31 | 13.31 | 127.73 | -- | -- | -- | -- | 3,030,531.00 | -- | 11.35 | -- | 12.96 | 67.92 | 60.85 | 10.43 | 14.75 | -- | 47.92 | -- | 6.34 | 8.50 | 9.42 | -12.59 | 2.15 | 25.37 | -- |
| Shilpa Medicare Ltd | 14.32bn | 1.50bn | 63.92bn | 898.00 | 42.16 | -- | 23.85 | 4.46 | 7.75 | 7.75 | 73.87 | -- | -- | -- | -- | 15,945,910.00 | -- | 2.02 | -- | 2.61 | 70.47 | 60.07 | 10.48 | 5.17 | -- | 4.67 | -- | 9.89 | 11.71 | 7.22 | 145.63 | -12.90 | 16.09 | -- |
| Aarti Pharmalabs Ltd | 18.01bn | 2.14bn | 64.29bn | 2.16k | 30.08 | -- | 20.56 | 3.57 | 23.58 | 23.58 | 200.27 | -- | -- | -- | -- | 8,324,436.00 | -- | -- | -- | -- | 53.87 | -- | 11.87 | -- | -- | 9.34 | -- | -- | 14.17 | -- | 25.59 | -- | -- | -- |
| Blue Jet Healthcare Ltd | 10.53bn | 2.94bn | 68.92bn | 491.00 | 23.46 | -- | 21.81 | 6.54 | 16.93 | 16.93 | 60.76 | -- | -- | -- | -- | 21,448,020.00 | -- | -- | -- | -- | 53.75 | -- | 27.88 | -- | -- | 59.81 | -- | -- | 44.74 | -- | 86.38 | -- | -- | -- |
| Akums Drugs and Pharmaceuticals Ltd | 41.08bn | 3.17bn | 69.10bn | 7.54k | 21.80 | 2.19 | 14.32 | 1.68 | 20.71 | 20.71 | 268.25 | 205.66 | 0.8712 | 3.69 | 4.85 | 5,450,531.00 | 6.86 | -- | 8.82 | -- | 41.18 | -- | 7.87 | -- | 3.18 | 4.98 | 0.0277 | -- | -1.44 | -- | 8,481.07 | -- | -- | -- |
| Sudeep Pharma Ltd | 6.17bn | 1.68bn | 75.49bn | -- | 43.85 | -- | 41.10 | 12.24 | 15.24 | 15.24 | 55.94 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 63.01 | -- | 27.56 | -- | -- | 55.99 | -- | -- | 9.40 | -- | 4.19 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Supriya Lifescience Ltd's reporting currency: Indian Rupee INR
3.43%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Aditya Birla Sun Life Insurance Co. Ltd.as of 30 Jan 2026 | 1.68m | 2.09% |
| ITI Asset Management Ltd. (India)as of 31 Jan 2026 | 299.82k | 0.37% |
| PineBridge Investments Asia Ltd.as of 30 Jun 2025 | 200.00k | 0.25% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 174.28k | 0.22% |
| Grandeur Peak Global Advisors LLCas of 31 Oct 2025 | 122.54k | 0.15% |
| Quantum Asset Management Co. Pvt Ltd.as of 31 Jan 2026 | 92.59k | 0.12% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Dec 2025 | 88.87k | 0.11% |
| WhiteOak Capital Asset Management Ltd.as of 31 Dec 2025 | 57.63k | 0.07% |
| SSgA Funds Management, Inc.as of 05 Feb 2026 | 22.64k | 0.03% |
| Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 30 Jan 2026 | 22.18k | 0.03% |
More ▼
Data from 31 Dec 2025 - 31 Jan 2026Source: FactSet Research Systems Inc.
